Endo's Par Pharma recalls one batch of its Remodulin generic over particulate concerns
Endo's Par Pharma recalls one batch of its Remodulin generic over particulate concerns zbecker Tue, 03/12/2024 - 16:16
Endo's Par Pharma recalls one batch of its Remodulin generic over particulate concerns zbecker Tue, 03/12/2024 - 16:16
Acadia to end Nuplazid testing after schizophrenia trial flop and years of failed expansion efforts zbecker Tue, 03/12/2024 - 10:51
Pfizer aims Adcetris for expansion into large B-cell lymphoma after trial win aliu Tue, 03/12/2024 - 10:17
Amid Moderna's 'transition year,' CEO Stéphane Bancel's total pay fell by about 5% fkansteiner Tue, 03/12/2024 - 09:59
Cellares hits manufacturing milestone for its cell therapy factory-in-a-box kdunleavy Tue, 03/12/2024 - 09:56
After transformation under new CEO, Leo Pharma touts innovation model and financial progress kdunleavy Tue, 03/12/2024 - 07:31